missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ TRAIL R3/ TNFRSF10C Human ELISA Kit

Sandwich ELISA Kit

Brand:  Invitrogen™ EHTNFRSF10CX10

 View more versions of this product

Product Code. 17854220

  • £4280.00 / Pack of 10
Estimated Shipment: 28-01-2025
to see stock.
Explore more special offers
Add to basket
This item is not returnable. View return policy

Description

Description

The Human TRAIL R3/TNFRSF10C (TRAIL R3) ELISA quantitates Hu TRAIL R3 in human serum, plasma, or cell culture medium. The assay will exclusively recognize both natural and recombinant Hu TRAIL R3. Principle of the method The Human TRAIL R3 solid-phase sandwich ELISA (enzyme-linked immunosorbent assay) is designed to measure the amount of the target bound between a matched antibody pair. A target-specific antibody has been pre-coated in the wells of the supplied microplate. Samples, standards, or controls are then added into these wells and bind to the immobilized (capture) antibody. The sandwich is formed by the addition of the second (detector) antibody, a substrate solution is added that reacts with the enzyme-antibody-target complex to produce measurable signal. The intensity of this signal is directly proportional to the concentration of target present in the original specimen. Rigorous validation Each manufactured lot of this ELISA kit is quality tested for criteria such as sensitivity, specificity, precision, and lot-to-lot consistency. See manual for more information on validation.

TRAIL-R3 (tumor necrosis factor receptor superfamily member 10C) is a receptor for the cytotoxic ligand TRAIL. It lacks a cytoplasmic death domain which means it is not capable of inducing apoptosis. TRAIL-R3 may protect cells against TRAIL mediate apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand. TRAIL-R3's gene was found to be a p53-regulated DNA damage-inducible gene. The expression of the gene was detected in many normal tissues but not in most cancer cell lines, which may explain the specific sensitivity of cancer cells to the apoptosis-inducing activity of TRAIL.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

O14798
15 pg/mL
Solid-phase sandwich ELISA
ELISA Kit
Plasma, Serum, Supernatant
10 x 96 assays
ELISA, Protein Assays, Protein Biology, Cancer Biology, Immunology, Neuroscience, Neurobiology, Protein Detection, Protein Analysis
8794
<12%
Biotinylated Detection Antibody, Chromogen, Wash Buffer, Stop Solution, Adhesive Plate Covers, Standard, SAV-HRP, Assay Diluent concentrate, Pre-coated 96 well plate
10 x 96 Tests
Apoptosis
2°C to 8°C
Human
4 hr. 45 min.
16.38 to 4000 pg/mL
15 pg/mL to 4000 pg/mL
Biotin
Other Proteins
This ELISA kit shows no cross-reactivity with the following cytokines tested: human Angiogenin, BDNF, BLC, CNTF, ENA- 78, FGF-4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL- 11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, FGF-4, FGF-6, FGF- 7, G-CSF, GDNF, GM-CSF, IFN-gamma, IGFBP-2, IGFBP-3, IGFBP-4, Leptin (OB), MCP-1, MCP-2, MCP-3, MDC, MIF, MIG, MIP-1 alpha, MIP-1 beta, MIP-1 delta, PARC, PDGF, RANTES, SCF, SDF-1 alpha, TARC, TGF-beta, TIMP-1, TIMP-2, TNF-alpha, TNF-beta, TPO, VEGF.
Human
Colorimetric Microplate Reader
CD263,DCR1,DCR1-TNFR,LIT,TRAIL-R3,TRAILR3,TRID
<10%
HRP
RUO
Plasma, 33 μL; Serum, 33 μL; Supernatant, 100 μL
UNQ321/PRO366, CD263, DCR1, DCR1-TNFR, LIT, TRAIL-R3, TRAILR3, TRID
1 hr. 20 min.
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Special Offers

Special Offers

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.